Therefore, investigating asymptomatic C9orf72 repeat expansion carriers might provide non-invasively new insights into the pathophysiology of ALS and possible pre-symptomatic alterations, and some metabolic changes have been documented in many brain regions using both 1H MRS and 31P MRS. Here, C9orf72 is linked to amyotrophic lateral sclerosis.